Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1653
This examiner grants 28% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 16484869 | Method of Making Proteins with Non-Standard Amino Acids | Non-Final OA | President and Fellows of Harvard College |
| 18280986 | CORYNEBACTERIUM GLUTAMICUM VARIANT HAVING IMPROVED L-LYSINE PRODUCTION ABILITY, AND METHOD FOR PRODUCING L-LYSINE BY USING SAME | Non-Final OA | CJ CHEILJEDANG CORPORATION |
| 17786864 | INCREASING SPACE-TIME-YIELD, CARBON-CONVERSION-EFFICIENCY AND CARBON SUBSTRATE FLEXIBILITY IN THE PRODUCTION OF FINE CHEMICALS | Final Rejection | BASF SE |
| 17605919 | BETA-AMYLASE VARIANTS | Final Rejection | BASF SE |
| 17793009 | 4-UREIDO-5-CARBOXYL-IMIDAZOLE-AMIDE HYDROLASE AND USE THEREOF | Non-Final OA | TIANJIN UNIVERSITY |
| 17041851 | REAL-TIME MONITORING OF PROTEIN CONCENTRATION USING ULTRAVIOLET SIGNAL | Final Rejection | BRISTOL-MYERS SQUIBB COMPANY |
| 17617466 | COSMETIC COMPOSITION COMPRISING A COMBINATION OF AT LEAST ONE OLIGOSACCHARIDE AND/OR POLYSACCHARIDE COMBINED WITH A MANNOSE MONOSACCHARIDE, AND USE THEREOF IN MAINTAINING THE BALANCE OF THE BACTERIAL SKIN FLORA | Non-Final OA | L'OREAL |
| 17925662 | Agent for Increasing Content of IgA Antibody in Milk | Non-Final OA | THE UNIVERSITY OF TOKYO |
| 17414288 | FORMULATIONS FOR EGG ORAL IMMUNOTHERAPY, METHODS OF MANUFACTURE, AND TREATMENTS FOR EGG ALLERGY | Non-Final OA | Société des Produits Nestlé S.A. |
| 18255344 | SYNTHETIC MIXED CULTURE RESEMBLING A SKIN MICROBIOME | Non-Final OA | Evonik Operations GmbH |
| 17924243 | METHOD FOR PRODUCING HIGHER LINEAR FATTY ACIDS OR ESTERS | Final Rejection | EVONIK OPERATIONS GMBH |
| 17769047 | PROGRAMMABLE RNA EDITING PLATFORM | Non-Final OA | NANYANG TECHNOLOGICAL UNIVERSITY |
| 17507800 | Mutant Glucose Dehydrogenase Having Improved Thermal Stability, and Use Thereof | Non-Final OA | ARKRAY, Inc. |
| 18350982 | METHOD FOR PRODUCING PHYTOSPHINGOSINE OR PHYTOCERAMIDE | Non-Final OA | DANSTAR FERMENT AG |
| 17754049 | METHOD FOR SCREENING SECRETION-PRODUCING CELLS AND KIT FOR SCREENING SECRETION-PRODUCING CELLS | Final Rejection | Tokyo Ohka Kogyo Co., Ltd. |
| 17924704 | THERMOSTABLE GLUCOCEREBROSIDASE | Non-Final OA | TEIKYO UNIVERSITY |
| 18006798 | Compositions and Methods for Treating Infections of the Gastrointestinal Tract | Final Rejection | Icahn School of Medicine at Mount Sinai |
| 17613752 | COMPOSITIONS AND METHODS FOR PRODUCING STEVIOL GLYCOSIDES | Non-Final OA | Arzeda Corp. |
| 18253956 | METHOD FOR COLLECTING CELLS OF MICROORGANISM IN SPECIMEN | Final Rejection | KABUSHIKI KAISHA YAKULT HONSHA |
| 17768461 | PROTEIN PURIFICATION USING A SPLIT INTEIN SYSTEM | Non-Final OA | Cytiva Bioprocess R&D AB |
| 18264400 | FERMENTATION METHOD FOR MUPIROCIN | Non-Final OA | HANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL CO., LTD. |
| 18280926 | INACTIVATED STRAINS OF BACTERIA, SUCH AS VIABLE BUT NON-CULTURABLE BACTERIA, COMPOSITIONS AND USE THEREOF | Non-Final OA | BLL INVEST S.R.L. |
| 18455215 | LACTIC ACID BACTERIUM AND METHOD FOR PREVENTING OR TREATING ALLERGY BY ADMINISTERING SAME | Non-Final OA | Bened Biomedical Co., Ltd. |
| 18450612 | Recombinant Escherichia coli producing xylitol from xylose, method for preparing the same, and uses thereof | Non-Final OA | MYONGJI UNIVERSITY INDUSTRY AND ACADEMIA COOPERATION FOUNDATION |
| 17754400 | SEPARATION OF NEUTRAL OLIGOSACCHARIDES FROM FERMENTATION BROTH | Non-Final OA | Glycom A/S |
| 18030501 | Clotting Factor Variants and Their Use | Non-Final OA | Children's Healthcare of Atlanta |
| 18188995 | RECOMBINANT MICROORGANISM AND A METHOD FOR ITACONIC ACID PRODUCTION | Non-Final OA | NATIONAL CHEN KUNG UNIVERSITY |
| 18041805 | BACILLUS ALTITUDINIS AND APPLICATION OF ACTIVE SUBSTANCE COMPOUND SOLUTION AND MICROBIAL INOCULUM THEREOF IN CONTROL OF ROOT-KNOT NEMATODE DISEASE | Final Rejection | SHANDONG AGRICULTURAL UNIVERSITY |
| 17625440 | TREATMENT OF GLYCOGEN STORAGE DISEASE (GSD) | Non-Final OA | UNIVERSITE D'EVRY VAL D'ESSONNE |
| 17916767 | CULTURE MEDIUM, FUNGUS BED, BAGGED FUNGUS BED, CULTURE MEDIUM MANUFACTURING METHOD, FUNGUS BED MANUFACTURING METHOD, BAGGED FUNGUS BED MANUFACTURING METHOD | Final Rejection | LaLa Corporation |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy